EUVIMEDEUVIMED entdecken
CrossrefInfokarte

Biochemical Characteristics, Treatment, and Outcomes of Thyrotoxicosis in Amiodarone-Treated Individuals with Prior Hypothyroidism

Afif Nakhleh, Limor Adler, Shirley Shapiro Ben David, Daniella Rahamim-Cohen, Ori Liran, Sagit Zolotov

Endocrine Connections · 2026-11-12

DOI: 10.1530/ec-26-0539 ↗
AbstractBibliografische Angaben

Abstract

Abstract Background Evidence regarding the transition from hypothyroidism to thyrotoxicosis in amiodarone-treated patients remains scarce. We compared clinical characteristics, treatments, and outcomes of amiodarone-exposed individuals developing thyrotoxicosis following hypothyroidism (post-hypo-T) versus those without prior thyroid disease (T-controls). Methods This retrospective cohort study utilized electronic health records from a large health maintenance organization (HMO). We included adults from the cardiovascular disease registry with new-onset thyrotoxicosis diagnosed between January 1, 2010, and December 31, 2022, who received amiodarone within the year preceding diagnosis. Follow-up ended on August 31, 2025. Cox regression models adjusted for age and sex were used to analyze outcomes. Results Of 558 individuals, 91 (16%) had prior hypothyroidism and 467 were controls. Post-hypo-T patients were older (70.4±10.1 vs. 67.4±11.0 years; p = 0.02) and had a higher proportion of males (44.0% vs. 25.3%; p < 0.001). Median amiodarone exposure prior to diagnosis was 2.7 versus 2.8 years, respectively (p = 0.01). At diagnosis, post-hypo-T individuals had lower median free thyroxine (fT4) levels (27.0 vs. 31.3 pmol/L; p < 0.001) and free triiodothyronine (fT3) levels (6.4 vs. 7.5 pmol/L; p < 0.001). Over a 7.8-year median follow-up, antithyroid medications were used less frequently in post-hypo-T individuals (37.4% vs. 54.0%; p = 0.004). Glucocorticoid use was numerically lower in post-hypo-T individuals (26.4% vs. 38.5%; p = 0.06). Post-hypo-T individuals had a higher incidence of hypothyroidism requiring levothyroxine (64.8% vs. 17.8%; p < 0.001). Conclusions Among amiodarone-exposed individuals who develop thyrotoxicosis, those with prior hypothyroidism have a milder biochemical presentation, less frequent use of antithyroid drugs or glucocorticoids, and a higher likelihood of recurrent hypothyroidism requiring levothyroxine.

Wissen, das zu Ihrer Arbeit passt.

Vom kostenlosen Einstieg über die persönliche Recherche bis zur vollständigen Research Suite.

Tarife ansehen →

Sind alle Verlagsvolltexte enthalten?

Nein. Bibliografische Nachweise, Abstracts und Volltexte sind unterschiedliche Inhalte. Ob ein Volltext verfügbar ist, hängt von der Quelle, Open Access und Ihren vorhandenen Lizenzen ab. Ein EUVIMED-Tarif ersetzt keine zusätzlichen Verlagsrechte.

Tarife ansehen →